Public and private M&A

Advised a leading healthcare service provider on the acquisition of a specialist clinic of a reputable ear nose and throat surgeon in Singapore.

Advised on the acquisition of a private microfinancing business in the Philippines.

Advised a Catalist-listed offshore subsea marine engineering company on the acquisition of Malaysia's oldest post-natal confinement care centre.

Advised on the acquisition of a human resources consultancy and outsourcing business by a business process outsourcing (BPO) company based in Singapore and Malaysia.

Advised a Mainboard-listed private healthcare group on its acquisition of a 51% stake in a company involved in the manufacture, sale and distribution of diagnostic test kits for viruses such as COVID-19.

Corporate

Advised a Singapore-based venture capital fund on their series A investment in a human resources microfinancing business in the Philippines.

Advised a Chinese-backed venture capital fund on their series A investment in Singapore-based fintech startup focusing on digital payments and solutions.

Advised one of the largest providers of renewable power to commercial and industrial entities in India on multiple financing transactions in relation to renewable energy projects in India.

Equity capital markets

Advised a Catalist-listed mining company on its debt restructuring exercise involving multiple rounds of fund-raising, the disposal of its principal operating subsidiary, and the rescue financing by a white knight investor as part of a settlement package with various bondholders of the Company.

Advised a Catalist-listed food and beverage, travel and lifestyle company on its debt restructuring exercise, involving the disposal of operating subsidiaries in Japan and the US and a renounceable rights cum warrants  issue exercise for the settlement of outstanding liabilities.

Advised a Catalist-listed company on its diversification into the fintech business, change of name, and the establishment of a digital asset custodian business.

Advised a Mainboard-listed private healthcare group on a RMB500 million disposal of its associate stake in a manufacturer and distributor of specialised dental equipment and supplies in the People’s Republic of China.

Advised a Catalist-listed offshore subsea marine engineering company on the diversification of its business into the healthcare and wellness industry and the disposal of its principal operating subsidiary.